REMEDIS

Established in May 2021, Singhealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) was set up, to advance the efforts in regenerative medicine research by exploring the potential of regenerating diseased cells, tissue and even organs to develop research, regenerative therapies and tools to tackle age-related diseases and chronic conditions. Regenerative medicine is expected to have a significant impact in reducing the burden of age-related and chronic disease.

REMEDIS will focus efforts on 7 disease areas:

• Musculoskeletal diseases

• Bone marrow disorders

• Blood disorders

• Cardiovascular diseases

• Acute and Chronic Wound Healing

• Neuro-sensory diseases

• Eye diseases

REMEDIS will work towards its vision of 'Restoring Function and Embracing Life' in collaboration with multidisciplinary research hubs and local clinical groups.

Follow REMEDIS and the developments of regenerative medicine here.